THE USE OF WEEKLY ORAL DOSES OF SULFAMETHOXYPYRIDAZINE FOR RHEUMATIC FEVER PREVENTION

被引:11
作者
JOHNSON, EE
MATHEWS, MJ
STOLLERMAN, GH
机构
关键词
D O I
10.1016/S0022-3476(59)80105-0
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:468 / 473
页数:6
相关论文
共 16 条
[1]   DETERMINATION OF C-REACTIVE PROTEIN IN THE BLOOD AS A MEASURE OF THE ACTIVITY OF THE DISEASE PROCESS IN ACUTE RHEUMATIC FEVER [J].
ANDERSON, HC ;
MCCARTY, M .
AMERICAN JOURNAL OF MEDICINE, 1950, 8 (04) :445-455
[2]  
Bratton AC, 1939, J BIOL CHEM, V128, P537
[3]  
FRISK AR, 1956, 4TH ANN ANT S WASH
[4]  
GRIEBLE HG, 1958, NEW ENGL J MED, V25, P1
[5]   The dianosis of rheumatic fever [J].
Jones, TD .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1944, 126 :481-484
[6]   USE OF SULFAMETHOXYPYRIDAZINE IN THE PREVENTION OF STREPTOCOCCAL INFECTIONS IN RHEUMATIC PATIENTS [J].
LEPPER, MH ;
SIMON, AJ ;
MARIENFELD, CJ .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1957, 69 (03) :485-492
[7]  
NICHOLS RL, 1957, J LAB CLIN MED, V49, P410
[8]  
RANTZ LA, 1945, P SOC EXP BIOL MED, V59, P22
[9]  
SCHULTZ I, AM J M SC
[10]   THROMBOCYTOPENIA AND LEUKOPENIA ASSOCIATED WITH USE OF SULFAMETHOXYPYRIDAZINE [J].
SCHWARTZ, MJ ;
NORTON, WS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1958, 167 (04) :457-459